Anti-inflammatory Drugs Market, by Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives (ImSAIDs), Anti-inflammatory Biologics, and Corticosteroids), by Application (Arthritis, Chronic Obstructive Pulmon

Anti-inflammatory Drugs Market, by Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives (ImSAIDs), Anti-inflammatory Biologics, and Corticosteroids), by Application (Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Gout, and Others), by Route of Administration (Oral, Topical, Injection, and Inhalation), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Anti-inflammatory drugs are used in the treatment of acute and chronic diseases with inflammatory etiology. Therapeutic delivery of anti-inflammatory drugs to the target site of action and simultaneously avoiding undesired side effects. Anti-inflammatory drug supports to improve the quality of life and management of several rheumatic conditions such as arthritis. Anti-inflammatory drugs, especially the non-steroidal forms has significant role in medical practice, which has strong potential to boost the market growth in the near future.
Market Dynamics
Rising incidence of acute and chronic diseases such as arthritis is expected to drive anti-inflammatory drugs market growth. For instance, according to an article published by the Morbidity and Mortality Weekly Report, an epidemiological digest Centers for Disease Control and Prevention (CDC) in 2017, reports that arthritis affects over 1 in 4 adults and in rural areas in the U.S., 1 in 3 adults has arthritis.
However, side effects of anti-inflammatory drugs are expected to hinder the market growth. For instance, according to an article published by the healthdirect, Australia in January 2020, reports that the anti-inflammatory medicines may also trigger asthma in some people. The same source also states that children under 16 years must not be prescribed aspirin due to the rare occurrence of Reye’s syndrome, which is potentially fatal.
Key features of the study:
This report provides in-depth analysis of the global anti-inflammatory drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global anti-inflammatory drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy’s Laboratories among others
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global anti-inflammatory drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-inflammatory drugs market.
Detailed Segmentation:
Global Anti-inflammatory Drugs Market, By Drug Type:
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Anti-inflammatory Biologics
Corticosteroids
Global Anti-inflammatory Drugs Market, By Application:
Arthritis
Chronic Obstructive Pulmonary Disease (COPD)
Multiple Sclerosis
Inflammatory Bowel Disease (IBD)
Gout
Others
Global Anti-inflammatory Drugs Market, By Route of Administration:
Oral
Topical
Injection
Inhalation
Global Anti-inflammatory Drugs Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Anti-inflammatory Drugs Market, By Region:
North America
By Drug Type:
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Anti-inflammatory Biologics
Corticosteroids
By Application:
Arthritis
Chronic Obstructive Pulmonary Disease (COPD)
Multiple Sclerosis
Inflammatory Bowel Disease (IBD)
Gout
Others
By Route of Administration:
Oral
Topical
Injection
Inhalation
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Drug Type:
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Anti-inflammatory Biologics
Corticosteroids
By Application:
Arthritis
Chronic Obstructive Pulmonary Disease (COPD)
Multiple Sclerosis
Inflammatory Bowel Disease (IBD)
Gout
Others
By Route of Administration:
Oral
Topical
Injection
Inhalation
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Type:
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Anti-inflammatory Biologics
Corticosteroids
By Application:
Arthritis
Chronic Obstructive Pulmonary Disease (COPD)
Multiple Sclerosis
Inflammatory Bowel Disease (IBD)
Gout
Others
By Route of Administration:
Oral
Topical
Injection
Inhalation
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Type:
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Anti-inflammatory Biologics
Corticosteroids
By Application:
Arthritis
Chronic Obstructive Pulmonary Disease (COPD)
Multiple Sclerosis
Inflammatory Bowel Disease (IBD)
Gout
Others
By Route of Administration:
Oral
Topical
Injection
Inhalation
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Type:
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Anti-inflammatory Biologics
Corticosteroids
By Application:
Arthritis
Chronic Obstructive Pulmonary Disease (COPD)
Multiple Sclerosis
Inflammatory Bowel Disease (IBD)
Gout
Others
By Route of Administration:
Oral
Topical
Injection
Inhalation
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Type:
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Anti-inflammatory Biologics
Corticosteroids
By Application:
Arthritis
Chronic Obstructive Pulmonary Disease (COPD)
Multiple Sclerosis
Inflammatory Bowel Disease (IBD)
Gout
Others
By Route of Administration:
Oral
Topical
Injection
Inhalation
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Pfizer, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
GlaxoSmithKline plc
Johnson & Johnson Services Inc.
Merck & Company, Inc.
Novartis AG
Amgen, Inc.
AstraZeneca plc
Eli Lily and Company
AbbVie Inc.
F. Hoffmann-La Roche AG
Bristol Myers Squibb Company
Biogen Inc.
Sun Pharmaceutical Industries Ltd
Mylan, Inc.
Aurobindo Pharma Limited
Dr. Reddy’s Laboratories
“*” marked represents similar segmentation in other categories in the respective section.